Financials
Financial year 2025
Gross margin
€ 296,218
▲ 118115% vs 2024
Profit
Growing€ 120,628
▲ 44% vs 2024
Debts
Low€ 343,314
▲ 30% vs 2024
2PHARMA from Gent, company number BE0886662746, closed financial year 2025 with a result of € 120,628 after tax. For that financial year 2PHARMA recorded a gross margin of € 296,218 and equity of € 779,467. Compared with financial year 2024, the result moved from € 83,988 to € 120,628. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
What happened at 2PHARMA?
What happened at 2PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Aquitania BV stepped down as director. NBB
- MD Consult BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 120,628 (▲ 44% vs 2024). Source: NBB ↗
- Aquitania BV became a director. NBB
- MD Consult BV became a director. NBB
- SDV Consult BV stepped down as director. NBB
- SDV Consult BV became a director. NBB
- New establishment in Gent. KBO
In short
From € 64,061 profit in 2021 to € 120,628 profit in 2025.
Paid € 56,766 in corporate taxes since 2021.
Best year ever: 2025, with € 120,628 profit.
A new publication or filing at 2PHARMA? We notify you, reason included.
Follow 2PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
since 2019 · until 2025
Director · represented by Anja Imschoot
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, b+pharma Belgium +6 more
since 2026 · until 2032
Managing director · represented by Mario Debel
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, 2PHARMA HOLDING +5 more
since 2026 · until 2032
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1091 box B
9051 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
Ceres Pharmaceuticals same network
€ 14.6 million revenue · 2025
What's Cooking Group
KOUTERLOS
€ 55,337 gross margin · 2024
b+pharma Belgium same network
€ 287,023 gross margin · 2025
DGPharma same network
€ 94,120 gross margin · 2024
+15 more
Details
- Company number
- 0886.662.746
- VAT number
- BE 0886.662.746
- Registered office
- Kortrijksesteenweg 1091 bus B, 9051 Gent
- Names & denominations
- 2PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 19 January 2007
- Peppol
- Active · Active since 26 Aug 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen